Funding for this research was provided by:
Pfizer Canada (N/A)
Northern Ontario Academic Medicine Association (A-14-10 and A-17-06)
Text and Data Mining valid from 2019-11-12
Received: 7 August 2019
Accepted: 30 October 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: This study was approved by the research ethics boards of Lakehead University (approval reference number: 085 14–15) and the Thunder Bay Regional Health Sciences Centre (approval reference number: 2014124). Written informed consent was obtained from each participant prior to determination of eligibility.
: Not applicable.
: Pfizer provided funding for the study and was the supplier of the PCV13 vaccine used for the study.